Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07157722
PHASE3

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

The current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.

Official title: The Potential Role of N-Acetyl Cysteine or Alpha-Lipoic Acid as Adjuvant Therapies in the Treatment of Patients With Beta Thalassemia

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2025-08-30

Completion Date

2026-01-30

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

DRUG

Iron chelating intervention

JADENU is indicated for the treatment of chronic iron overload due to blood transfusions.

DRUG

N Acetyl cysteine 600mg

N-acetyl cysteine (NAC) 600 mg will be administered orally once daily for 12 weeks.

DRUG

Alpha Lipoic Acid 600 MG Oral Tablets

Alpha lipoic acid (ALA) 600 mg will be administered orally once daily for 12 weeks.

Locations (1)

Faculty of Pharmacy - Tanta University

Tanta, Egypt